Edward Miller - Net Worth and Insider Trading

Edward Miller Net Worth

The estimated net worth of Edward Miller is at least $4 Million dollars as of 2024-11-05. Edward Miller is the SVP, Chief Compliance Officer of Alexion Pharmaceuticals Inc and owns about 19,284 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $4 Million. Edward Miller is also the General Counsel of AlloVir Inc and owns about 503,002 shares of AlloVir Inc (ALVR) stock worth over $477,852. Details can be seen in Edward Miller's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Edward Miller has not made any transactions after 2024-10-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Edward Miller

To

Edward Miller Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Edward Miller owns 2 companies in total, including AlloVir Inc (ALVR) , and Alexion Pharmaceuticals Inc (ALXN) .

Click here to see the complete history of Edward Miller’s form 4 insider trades.

Insider Ownership Summary of Edward Miller

Ticker Comapny Transaction Date Type of Owner
ALVR AlloVir Inc 2024-10-22 General Counsel
ALXN Alexion Pharmaceuticals Inc 2017-02-28 SVP & Chief Compliance Officer

Edward Miller Latest Holdings Summary

Edward Miller currently owns a total of 2 stocks. Among these stocks, Edward Miller owns 19,284 shares of Alexion Pharmaceuticals Inc (ALXN) as of February 28, 2017, with a value of $4 Million and a weighting of 88.05%. Edward Miller also owns 503,002 shares of AlloVir Inc (ALVR) as of October 22, 2024, with a value of $477,852 and a weighting of 11.95%.

Latest Holdings of Edward Miller

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALXN Alexion Pharmaceuticals Inc 2017-02-28 19,284 182.50 3,519,330
ALVR AlloVir Inc 2024-10-22 503,002 0.95 477,852

Holding Weightings of Edward Miller


Edward Miller Form 4 Trading Tracker

According to the SEC Form 4 filings, Edward Miller has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 590 shares on February 28, 2017, which brought Edward Miller around $77,573.

According to the SEC Form 4 filings, Edward Miller has made a total of 19 transactions in AlloVir Inc (ALVR) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in AlloVir Inc is the sale of 1,401 shares on October 22, 2024, which brought Edward Miller around $1,079.

Insider Trading History of Edward Miller

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Edward Miller Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Edward Miller Ownership Network

Ownership Network List of Edward Miller

No Data

Ownership Network Relation of Edward Miller

Insider Network Chart

Edward Miller Owned Company Details

What does AlloVir Inc do?

Who are the key executives at AlloVir Inc?

Edward Miller is the General Counsel of AlloVir Inc. Other key executives at AlloVir Inc include director & 10 percent owner & See Remarks Vikas Sinha , Chief Accounting Officer Brett R Hagen , and 10 percent owner Gilead Sciences Inc .

AlloVir Inc (ALVR) Insider Trades Summary

Over the past 18 months, Edward Miller made 14 insider transaction in AlloVir Inc (ALVR) with a net sale of 21,755. Other recent insider transactions involving AlloVir Inc (ALVR) include a net sale of 182,774 shares made by Diana Brainard , a net sale of 63,842 shares made by Brett R Hagen , and a net sale of 76,956 shares made by Vikas Sinha .

In summary, during the past 3 months, insiders sold 31,263 shares of AlloVir Inc (ALVR) in total and bought 0 shares, with a net sale of 31,263 shares. During the past 18 months, 345,327 shares of AlloVir Inc (ALVR) were sold and 2,930,870 shares were bought by its insiders, resulting in a net purchase of 2,585,543 shares.

AlloVir Inc (ALVR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AlloVir Inc Insider Transactions

No Available Data

Edward Miller Mailing Address

Above is the net worth, insider trading, and ownership report for Edward Miller. You might contact Edward Miller via mailing address: C/o Alexion Pharmaceuticals, Inc, 352 Knotter Drive, Cheshire Ct 06410.